Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
Table 1. Predicted minimum cost per person for 12 week course of DAA
HCV DAA Patent expiry Class/daily dose Total dose (12 wk) Predicted cost (US $)
ribavirin generic NRTI/1200 mg 84g $20-63
daclatasvir 2027 NS5a/60 mg 5g $10-30
sofosbuvir 2029 NtRTI/400 mg 34g $68-136
faldaprevir 2029 PI/120 mg 10g $100-210
simeprevir 2026 PI/150 mg 13g $130-270
This does not make sense to me.. Seems backwards(?) Forgive my posting part of article here..